Geng J, Cui C, Yin Y, et al
doi:10.2174/092986710791299911 Zhu X, Su B, Wang X, Smith MA, Perry G
10.3969/j.issn.1671-9964.2018.01.007 136 YamazakiK.IshidaK.OtsuW.MuramatsuA.NakamuraS.YamadaW.et al (2024)
Well work with you to ensure your treatment is safe, effective, and tailored to your needs
A pill is easier to swallow (pun intended) and eliminates needle anxiety
What were building Neurophorol to enable (research-stage endpoints): receptor/pathway profiling + SAR learning neuroimmune and inflammation readouts oxidative stress / resilience markers reproducible preclinical validation workflows Were opening collaboration discussions with teams who can help validate and translate this platform responsibly: (Universities, Biotech companies, Tribal communities, and Investors) CB1/CB2 functional assays + signaling bias analytical chemistry (LCMS/NMR) + stability profiling neuroimmune models (microglia), biomarkers, preclinical design ADME/PK and translational study frameworks If you work in this space, comment NEUROPHOROL or DM your capability stack